2231029-82-4
2231029-82-4
Chemical Structure
Serplulimab
Synonym(s): HLX10
- CAS No.: 2231029-82-4
- Formula:N/A
- Molecular Weight:(144.18 kDa)
IUPAC Name: 3-(1H-pyrazol-1-yl)butan-2-amine
SMILES: [Serplulimab]
Biological Activity: Serplulimab (HLX 10) is a humanized anti-PD-1 monoclonal antibody. Serplulimab can inhibit tumor growth, regulate the tumor microenvironment, and has anti-tumor activity. Serplulimab can be used in the research of cancer such as lung cancer and colon cancer[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Serplulimab | 99.30% | Serplulimab (HLX 10) is a humanized anti-PD-1 monoclonal antibody. Serplulimab can inhibit tumor growth, regulate the tumor microenvironment, and has anti-tumor activity. Serplulimab can be used in the research of cancer such as lung cancer and colon cancer. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Zhang Y, et al. Insights into the mechanisms of serplulimab: a distinctive anti-PD-1 monoclonal antibody, in combination with a TIGIT or LAG3 inhibitor in preclinical tumor immunotherapy studies. MAbs. 2024 Jan-Dec;16(1):2419838. [Content Brief]
- [2]. Lee A. Serplulimab: First Approval. Drugs. 2022 Jul;82(10):1137-1141. [Content Brief]
